logo
Select company
Select metric
-42.45%Cash Return on Invested Capital
VS
Market
14
Sector
43
Industry
60
History
-
$ 35.28Close
$ 12.38 - $ 35.37 52-Week Range
Ticker Information

Ticker

ANAB

Company Name

ANAPTYSBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ANAPTYSBIO INC - Cash Return on Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ANAB - CROIC Historical data
DateCash Return on Invested CapitalFree Cash FlowInvested Capital
6/30/2025-42.45%$ -128.08M$ 301.72M
3/31/2025-28.73%$ -109.15M$ 379.98M
12/31/2024-30.82%$ -135.69M$ 440.33M
9/30/2024-22.9%$ -103.39M$ 451.43M
6/30/2024-33.41%$ -129.9M$ 388.81M
3/31/2024-35.74%$ -134.14M$ 375.35M
12/31/2023-29.18%$ -121.61M$ 416.72M
9/30/2023-21.75%$ -97.84M$ 449.89M
6/30/2023-16.56%$ -79M$ 477.18M
3/31/2023-15%$ -77.63M$ 517.67M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ANAPTYSBIO INC's latest trailing twelve months (TTM) CROIC stands at -18.85%.
  • Over the past 5 years, ANAPTYSBIO INC's average CROIC has been -17.78%.
  • The median CROIC for ANAPTYSBIO INC during this period was -15.78%
  • ANAPTYSBIO INC reached its highest CROIC over the past 5 years at 3.78%.
  • The lowest CROIC recorded by ANAPTYSBIO INC in the same timeframe -42.45%

ANAPTYSBIO INC's CROIC vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CROIC Benchmarks
CompanyCROIC
PHAT : PHATHOM PHARMACEUTICALS INC -186.8%NAGE : NIAGEN BIOSCIENCE INC 31.05%GYRE : GYRE THERAPEUTICS INC 0.08%CRMD : CORMEDIX INC 13.76%XNCR : XENCOR INC -16.24%TBPH : THERAVANCE BIOPHARMA INC 90.22%ZYME : ZYMEWORKS INC -11.46%KURA : KURA ONCOLOGY INC 37.81%ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -25.65%ZVRA : ZEVRA THERAPEUTICS INC -25.92%

Definition of Cash Return on Invested Capital

[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
FCF / Inv. Capital
(=) CROIC
CROIC for ANAPTYSBIO INC is calculated as follows: FCF [ $ -67.9M ] / Inv. Capital [ $ 360.24M ]
(=) CROIC [ -18.85% ]

ANAB - Cash Return on Invested Capital, Last 5 years

-42.45%

Minimum

Jun 30, 2025

3.78%

Maximum

Sep 30, 2021

-17.78%

Average

-15.78%

Median

CROIC Benchmark Analysis

The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.78% with a standard deviation of 15.05%.
The following table provides additional summary stats:
CROIC in the Market:
filtered constituents3.46K
min-43.78%
max49.3%
average2.78%
median4.97%
std15.05%